Androgenetic alopecia. New approved and unapproved treatments.

@article{Sawaya2000AndrogeneticAN,
  title={Androgenetic alopecia. New approved and unapproved treatments.},
  author={M. Sawaya and J. Shapiro},
  journal={Dermatologic clinics},
  year={2000},
  volume={18 1},
  pages={
          47-61, viii
        }
}
Although there are new FDA-approved drug therapies to treat hair loss, there are many unapproved agents with claims of effectively treating hair loss. A variety of new over-the-counter agents are available for consumers to use; however, it is difficult to assess how these agents work, costs of these agents, and efficacy. This article covers the new approved and the large multitude of unapproved treatments that are used to treat hair loss. 
Off-Label Uses for FDA-Approved Medications Spironolactone
tient setting. Frequently, patients conduct their own research on hair loss diagnosis and treatment and are faced with a number of manufacturers’ claims that their products will benefit hair loss.Expand
Guidelines for management of androgenetic alopecia based on BASP classification–the Asian consensus committee guideline
  • W. S. Lee, H. Lee, +9 authors M. Zheng
  • Medicine
  • Journal of the European Academy of Dermatology and Venereology : JEADV
  • 2013
TLDR
There is currently no published AGA guideline for Asian patients, and in comparison with Caucasian patients, Asian patients with AGA have different types of hair loss and family histories which may alter the treatment response. Expand
Characteristics of Androgenetic Alopecia in Asian
TLDR
Prevalence, hair loss patterns, familial factors, androgen receptor gene polymorphisms of Asian AGA patients, and management based on algorithmic guidelines for AGA are discussed. Expand
Androgenetic alopecia. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
TLDR
Algorithms recommended for the management of androgenetic alopecia in women and men are presented and medical literature indicates significantly more therapeutic options. Expand
Current therapies of female androgenetiC alopeCia and use of fluridil , a novel topiCal antiandrogen
Androgenetic alopecia (AGA) is the most common form of alopecia. As an androgen-dependent process, AGA miniaturises the hair follicles in genetically predisposed men and women. Currently, AGA inExpand
The Potential Role of Minoxidil in the Hair Transplantation Setting
  • M. Avram, John P. Cole, +7 authors C. Ziering
  • Medicine
  • Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 2002
TLDR
Based on the surgeons' clinical experience, the use of approved hair regrowth agents in hair transplant patients with viable but suboptimally functioning follicles in the region to be transplanted can increase hair density, speed regrowth in transplanted follicles, and complement the surgical result by slowing down or stopping further hair loss. Expand
Pharmacologic management of pattern hair loss.
  • R. Haber
  • Medicine
  • Facial plastic surgery clinics of North America
  • 2004
TLDR
Under-standing the proper role of pharmacology as it relates to surgical hair restoration and nonmedical options is crucial to provide patients with the best clinical, aesthetic, and psychological benefits. Expand
Molecular mechanisms of androgenetic alopecia
  • R. Trüeb
  • Biology, Medicine
  • Experimental Gerontology
  • 2002
TLDR
Current available treatment modalities with proven efficacy are oral finasteride, a competitive inhibitor of type 2 5 alpha-reductase, and topical minoxidil, an adenosine-triphosphate-sensitive potassium channel opener which has been reported to stimulate the production of vascular endothelial growth factor in cultured dermal papilla cells. Expand
Mini-Review Molecular mechanisms of androgenetic alopecia
Androgenetic alopecia (AGA) is hereditary and androgen-dependent, progressive thinning of the scalp hair that follows a defined pattern. While the genetic involvement is pronounced but poorlyExpand
Alopecia reason and possible treatments
TLDR
The significance of available recent therapies in the pharmacological management of hair loss which demands rational strategies for alopecia treatment is discussed and offers advantages like low side effects and cost improved patient compliance. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 42 REFERENCES
Hair regrowth. Therapeutic agents.
TLDR
The current state of the art agents for treatment of two of the most common forms of hair loss encountered in clinical practice, androgenetic alopecia and alopECia areata are reviewed. Expand
Alopecia - the search for novel agents continues
TLDR
A large number of currently available drugs indicated for other disease processes are still commonly used to treat the various forms of alopecia because no other agents are available; some of these compounds have severe side-effects and many also exhibit minimal efficacy. Expand
Alopecia areata. Update on therapy.
The treatment of alopecia areata has changed markedly in the past decade. Several options are now available to the patient. It is the dermatologist's duty to inform the patient of all the options,Expand
Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia
TLDR
In the untreated (control) group, mean values for total hair density may be necessary to improve hair quality and increase hair density, but further long-term studies are required to confirm these findings. Expand
Clinical updates in hair.
TLDR
Research findings indicate that levels of androgen-metabolizing enzymes and receptors differ in the scalps of women versus men, which may be important in formulating more effective hair growth treatments in the future. Expand
A double-blind, placebo-controlled study with Kevis lotion
TLDR
Androgenetic alopecia is characterized by an acceleration of the hair cycle, leading to a decrease in the growth time, without important modifications in the period of involution and in theperiod of follicle rest. Expand
Fatal and Nonfatal Hepatotoxicity Associated with Flutamide
TLDR
This article summarizes reports submitted to the Food and Drug Administration of patients with hepatotoxicity that may have been caused by flutamide and reviews reports that originated in domestic patient care settings. Expand
Effects of anabolic-androgenic steroids on the pilosebaceous unit.
Examination of skin biopsy specimens from persons using anabolic-androgenic steroids demonstrates dramatic hypertrophy of the sebaceous glands. High dosages of testosterone and anabolic-androgenicExpand
Side-effects of spironolactone therapy in the hirsute woman.
TLDR
Because of the incidence of metrorrhagia at higher dosages, it is recommended that spironolactone be administered cyclically at a starting dosage of 50 mg twice daily on days 4-21 of the menstrual cycle. Expand
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
Controversy regarding the relative efficacy of treatments for the relief of the symptoms of benign prostatic hyperplasia (BPH).
...
1
2
3
4
5
...